Ye Zhong

682 total citations
23 papers, 590 citations indexed

About

Ye Zhong is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ye Zhong has authored 23 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Ye Zhong's work include Molecular Sensors and Ion Detection (4 papers), Synthesis and Catalytic Reactions (3 papers) and Protein Degradation and Inhibitors (3 papers). Ye Zhong is often cited by papers focused on Molecular Sensors and Ion Detection (4 papers), Synthesis and Catalytic Reactions (3 papers) and Protein Degradation and Inhibitors (3 papers). Ye Zhong collaborates with scholars based in China, United States and South Korea. Ye Zhong's co-authors include Yufang Xu, Weiping Zhu, Xuhong Qian, Eric V. Anslyn, Lei Cui, Yi Xiao, Xin Wang, Katharine L. Diehl, J. Logan Bachman and Igor V. Kolesnichenko and has published in prestigious journals such as Chemical Communications, Journal of Materials Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Ye Zhong

20 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ye Zhong China 11 265 193 153 136 119 23 590
Zhongyu Wu China 16 387 1.5× 84 0.4× 185 1.2× 207 1.5× 188 1.6× 32 751
Michael J. Rishel United States 15 440 1.7× 259 1.3× 150 1.0× 141 1.0× 47 0.4× 21 816
Ruyi Jin China 16 138 0.5× 159 0.8× 69 0.5× 143 1.1× 58 0.5× 37 564
Kondapa Naidu Bobba India 17 176 0.7× 165 0.9× 193 1.3× 192 1.4× 223 1.9× 32 721
Yuxia Wang China 15 349 1.3× 176 0.9× 56 0.4× 67 0.5× 38 0.3× 49 671
Shen‐Zhen Ren China 14 168 0.6× 289 1.5× 297 1.9× 176 1.3× 31 0.3× 23 762
Stephen P. Wren United Kingdom 16 439 1.7× 312 1.6× 115 0.8× 75 0.6× 70 0.6× 33 910
Kasipandi Vellaisamy Macao 16 406 1.5× 203 1.1× 147 1.0× 312 2.3× 212 1.8× 21 884
Hongze Liao China 17 327 1.2× 424 2.2× 143 0.9× 86 0.6× 33 0.3× 34 783

Countries citing papers authored by Ye Zhong

Since Specialization
Citations

This map shows the geographic impact of Ye Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Zhong more than expected).

Fields of papers citing papers by Ye Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Zhong. The network helps show where Ye Zhong may publish in the future.

Co-authorship network of co-authors of Ye Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Zhong. A scholar is included among the top collaborators of Ye Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Zhong. Ye Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Ye, Jing Xu, Jie Gao, et al.. (2025). First ATG101-recruiting small molecule degrader for selective CDK9 degradation via autophagy–lysosome pathway. Acta Pharmaceutica Sinica B. 15(5). 2612–2624. 6 indexed citations
2.
Han, Jiajia, Yun He, Lin Xie, et al.. (2025). Design, synthesis and biological evaluation of dapsone derivatives with broad-spectrum antiviral activity. European Journal of Medicinal Chemistry. 293. 117717–117717.
4.
Xu, Jing, Ye Zhong, Yufei Zhang, et al.. (2025). Discovery and Administration Optimization of Novel Selective CDK9 Inhibitor, 1-7a-B1, for Improved Pharmacokinetics and Antitumor Efficacy In Vivo. Journal of Medicinal Chemistry. 68(11). 11586–11605.
5.
Zhong, Ye, Jing Xu, Yufei Zhang, et al.. (2024). Discovery of novel CDK9 inhibitor with tridentate ligand: Design, synthesis and biological evaluation. Bioorganic Chemistry. 150. 107550–107550. 2 indexed citations
6.
Xie, Yicheng, et al.. (2024). Lapagyl mitigates UV-induced inflammation and immunosuppression via Foxp3+ Tregs and CCL pathway: A single-cell transcriptomics study. Phytomedicine. 129. 155679–155679. 1 indexed citations
7.
Zhong, Ye, et al.. (2024). Synthesis and Antitumor Activity Evaluation of Novel Echinatin Derivatives with a 1,3,4-Oxadiazole Moiety. International Journal of Molecular Sciences. 25(4). 2254–2254. 4 indexed citations
8.
Zhong, Ye, et al.. (2021). Recent progress on betulinic acid and its derivatives as antitumor agents: a mini review. Chinese Journal of Natural Medicines. 19(9). 641–647. 31 indexed citations
9.
Zhong, Ye, et al.. (2021). Synthesis and antitumor activity evaluation of oleanolic acid saponins bearing an acetylated l-arabinose moiety. Carbohydrate Research. 503. 108311–108311. 7 indexed citations
10.
Zhang, Zuopeng, et al.. (2021). Synthesis, Molecular Docking Analysis and Biological Evaluations of Saccharide-Modified Thiadiazole Sulfonamide Derivatives. International Journal of Molecular Sciences. 22(11). 5482–5482. 7 indexed citations
11.
Zhang, Zuopeng, Ye Zhong, Yueqing Wang, et al.. (2021). Synthesis, Molecular Docking Analysis, and Biological Evaluations of Saccharide-Modified Sulfonamides as Carbonic Anhydrase IX Inhibitors. International Journal of Molecular Sciences. 22(24). 13610–13610. 2 indexed citations
12.
Diehl, Katharine L., Igor V. Kolesnichenko, Scott A. Robotham, et al.. (2016). Click and chemically triggered declick reactions through reversible amine and thiol coupling via a conjugate acceptor. Nature Chemistry. 8(10). 968–973. 98 indexed citations
13.
Zhou, Li, Ye Zhong, Mengzhu Xue, et al.. (2014). Design, synthesis and evaluation of PPAR gamma binding activity of 2-thioxo-4-thiazolidinone derivatives. Chinese Chemical Letters. 26(1). 63–68. 19 indexed citations
14.
Zhong, Ye, Mengzhu Xue, Xue Zhi Zhao, et al.. (2013). Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure–activity relationship analysis. Bioorganic & Medicinal Chemistry. 21(7). 1724–1734. 25 indexed citations
15.
Yuan, Jun, Ye Zhong, Shiliang Li, et al.. (2013). Triazole and Benzotriazole Derivatives as Novel Inhibitors for p90 Ribosomal S6 Protein Kinase 2: Synthesis, Molecular Docking and SAR Analysis. Chinese Journal of Chemistry. 31(9). 1192–1198. 6 indexed citations
16.
Zhong, Ye, Yufang Xu, & Eric V. Anslyn. (2013). Studies of Reversible Conjugate Additions. European Journal of Organic Chemistry. 2013(23). 5017–5021. 54 indexed citations
17.
Zhong, Ye, Chung-Oui Hong, Kwang‐Won Lee, et al.. (2011). Plasma Caffeic Acid Is Associated with Statistical Clustering of the Anticolitic Efficacy of Caffeic Acid in Dextran Sulfate Sodium-Treated Mice. Journal of Nutrition. 141(11). 1989–1995. 11 indexed citations
18.
Cui, Lei, Ye Zhong, Weiping Zhu, et al.. (2011). A New Prodrug-Derived Ratiometric Fluorescent Probe for Hypoxia: High Selectivity of Nitroreductase and Imaging in Tumor Cell. Organic Letters. 13(5). 928–931. 199 indexed citations
19.
Cui, Lei, Ye Zhong, Weiping Zhu, Yufang Xu, & Xuhong Qian. (2010). Selective and sensitive detection and quantification of arylamine N-acetyltransferase 2 by a ratiometric fluorescence probe. Chemical Communications. 46(38). 7121–7121. 37 indexed citations
20.
He, Chunsheng, Weiping Zhu, Yufang Xu, et al.. (2010). Ratiometric and reusable fluorescent nanoparticles for Zn2+ and H2PO4− detection in aqueous solution and living cells. Journal of Materials Chemistry. 20(47). 10755–10755. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026